The insulin-treated patients showed, also after adjustment for confounders, a statistically higher rate of MACE than patients without diabetes (31.3 % vs. 16.4 %, HR: 2.00 95 % CI: 1.29–3.12, p = 0.002). This evidence concerns the gene INS and diabetes mellitus.